Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection

被引：63
|
作者：
Campbell, S [1 ]
Ghosh, S [1 ]
机构：
[1] Western Gen Hosp, Gastrointestinal Unit, Dept Med Sci, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2001年 / 13卷 / 02期
关键词：
Crohn's disease; hepatitis C; infliximab; tumour necrosis factor alpha;
D O I：
10.1097/00042737-200102000-00016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Treatment of Crohn's disease with infliximab is an important drug therapy for patients with refractory and fistulating disease. There are concerns over its use in a proportion of Crohn's patients with concurrent hepatitis C infection, since there are theoretical risks of accelerated hepatic decompensation due to the immunomodulatory impact of infliximab. We report a patient with both Crohn's disease and ongoing active hepatitis C infection who underwent infliximab therapy, with no worsening of his liver function or PCR status. Eur J Gastroenterol Hepatol 13:191-192 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [31] Infliximab therapy in Crohn's disease: safety issues
    Hommes, DW
    van Deventer, SJH
    NETHERLANDS JOURNAL OF MEDICINE, 2003, 61 (04): : 100 - 104
  • [32] Metastatic Crohn's disease despite infliximab therapy
    Campos, Sara
    Coutinho, Ines
    Cardoso, Jose Carlos
    Portela, Francisco
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2017, 92 (05) : 104 - 106
  • [33] Infliximab therapy in Crohn's disease: a pragmatic approach?
    Kevans, D.
    Keegan, D.
    Mulcahy, H. E.
    O'Donoghue, D. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (02) : 351 - 359
  • [34] Infliximab therapy in pediatric Crohn's disease: a review
    Parashette, Kalyan Ray
    Makam, Raghavendra Charan
    Cuffari, Carmen
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2010, 3 : 57 - 63
  • [35] Sarcoidosis during infliximab therapy for Crohn's disease
    Takahashi, Hidetoshi
    Kaneta, Kazuhiro
    Honma, Masaru
    Ishida-Yamamoto, Akemi
    Ashida, Tomonori
    Kohgo, Yutaka
    Ohsaki, Yoshinobu
    Iizuka, Hajime
    JOURNAL OF DERMATOLOGY, 2010, 37 (05): : 471 - 474
  • [36] Maintenance therapy with subcutaneous infliximab for Crohn's disease
    Gomersall, Bethany
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (07): : 608 - 608
  • [37] Infliximab Therapy and Surgical Intervention for Crohn's Disease
    Hashida, Hiroki
    Kitano, Shoichi
    Kumata, Yukiko
    Kita, Ryosuke
    Masui, Hideyuki
    Sakamoto, Yusuke
    Kinoshita, Hiromitsu
    Iwamoto, Sena
    Mizumoto, Motoko
    Kondo, Masato
    Komori, Junji
    Kobayashi, Hiroyuki
    Uryuhara, Kenji
    Hosotani, Ryo
    Kaihara, Satoshi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S767 - S767
  • [38] Demyelination during infliximab therapy for Crohn's disease
    An, Y. K.
    Allsopp, S.
    Daveson, K. L.
    Daveson, A. J. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 155 - 155
  • [39] Interferon-Induced Crohn's Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection
    Basar, Omer
    Dailey, Francis
    Dailey, Erica
    Tahan, Veysel
    Daglilar, Ebubekir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [40] Disseminated mycobacterial infection mimicking erythema nodosum in a patient with Crohn's disease on infliximab therapy
    Cooper, EL
    Patterson, D
    Rakita, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S263 - S263
12345